Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1
A Chinese medicine granule, Shu-Feng-Xuan-Fei (SFXF), is critical for viral clearance in early phase of influenza virus infection. In this study, 72 ICR mice were randomly divided into six groups: normal control group, virus control group, Oseltamivir group, low-dose SFXF, medium-dose SFXF, and high...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2014/976364 |
id |
doaj-825b137c6e384ce1b0e8b705f4aa57db |
---|---|
record_format |
Article |
spelling |
doaj-825b137c6e384ce1b0e8b705f4aa57db2020-11-24T22:20:22ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882014-01-01201410.1155/2014/976364976364Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1Na-na Lu0Qi Liu1Li-gang Gu2Shi-jie Ge3Jun Wu4Qiu Ze-ji5Ze-ji Qiu6Hong-chun Zhang7En-xiang Chao8Zhuo-nan Yu9Laboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaLaboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaLaboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaLaboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaLaboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaLaboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaDepartment of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, ChinaDepartment of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, ChinaLaboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaLaboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, ChinaA Chinese medicine granule, Shu-Feng-Xuan-Fei (SFXF), is critical for viral clearance in early phase of influenza virus infection. In this study, 72 ICR mice were randomly divided into six groups: normal control group, virus control group, Oseltamivir group, low-dose SFXF, medium-dose SFXF, and high-dose SFXF. Mice were anesthetized and inoculated with 4LD50 of influenza virus A (H1N1) except normal control group. Oseltamivir group received 11.375 mg·kg−1·d−1 Oseltamivir Phosphate. SFXF 3.76, 1.88 and 0.94 g·kg−1·d−1 were administrated to mice in all SFXF groups. Each group was in equal dose of 0.2ml daily for 4 consecutive days. Mice were sacrificed and then total RNA was extracted in lung tissue. Some genes involved in T-cell-mediated immunity were selected by DNA microarray. These candidate genes were verified by Real-Time PCR and western immunoblotting. Compared with virus control group, in Toll-like receptor signaling pathway, 12 virus-altered genes were significantly reduced following medium-dose SFXF treatment. Eighteen antigen processing presentation-associated genes were upregulated by medium-dose SFXF. In the process of T cell receptor signaling pathway, 19 genes were downregulated by medium-dose SFXF treatment. On exploration into effector T cells activation and cytokines, all of altered genes in virus control group were reversed by medium-dose SFXF. Real-time PCR and western immunoblotting showed that the regulation of medium-dose SFXF in IL-4, IFN-γ, TNF-α, IL-1β, TLR7, MyD88, p38, and JNK was superior to Oseltamivir and high-dose SFXF group. Therefore, SFXF granules could reduce influenza infected cells and activation of T cells.http://dx.doi.org/10.1155/2014/976364 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Na-na Lu Qi Liu Li-gang Gu Shi-jie Ge Jun Wu Qiu Ze-ji Ze-ji Qiu Hong-chun Zhang En-xiang Chao Zhuo-nan Yu |
spellingShingle |
Na-na Lu Qi Liu Li-gang Gu Shi-jie Ge Jun Wu Qiu Ze-ji Ze-ji Qiu Hong-chun Zhang En-xiang Chao Zhuo-nan Yu Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1 Evidence-Based Complementary and Alternative Medicine |
author_facet |
Na-na Lu Qi Liu Li-gang Gu Shi-jie Ge Jun Wu Qiu Ze-ji Ze-ji Qiu Hong-chun Zhang En-xiang Chao Zhuo-nan Yu |
author_sort |
Na-na Lu |
title |
Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1 |
title_short |
Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1 |
title_full |
Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1 |
title_fullStr |
Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1 |
title_full_unstemmed |
Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1 |
title_sort |
gene expression profiles underlying selective t-cell-mediated immunity activity of a chinese medicine granule on mice infected with influenza virus h1n1 |
publisher |
Hindawi Limited |
series |
Evidence-Based Complementary and Alternative Medicine |
issn |
1741-427X 1741-4288 |
publishDate |
2014-01-01 |
description |
A Chinese medicine granule, Shu-Feng-Xuan-Fei (SFXF), is critical for viral clearance in early phase of influenza virus infection. In this study, 72 ICR mice were randomly divided into six groups: normal control group, virus control group, Oseltamivir group, low-dose SFXF, medium-dose SFXF, and high-dose SFXF. Mice were anesthetized and inoculated with 4LD50 of influenza virus A (H1N1) except normal control group. Oseltamivir group received 11.375 mg·kg−1·d−1 Oseltamivir Phosphate. SFXF 3.76, 1.88 and 0.94 g·kg−1·d−1 were administrated to mice in all SFXF groups. Each group was in equal dose of 0.2ml daily for 4 consecutive days. Mice were sacrificed and then total RNA was extracted in lung tissue. Some genes involved in T-cell-mediated immunity were selected by DNA microarray. These candidate genes were verified by Real-Time PCR and western immunoblotting. Compared with virus control group, in Toll-like receptor signaling pathway, 12 virus-altered genes were significantly reduced following medium-dose SFXF treatment. Eighteen antigen processing presentation-associated genes were upregulated by medium-dose SFXF. In the process of T cell receptor signaling pathway, 19 genes were downregulated by medium-dose SFXF treatment. On exploration into effector T cells activation and cytokines, all of altered genes in virus control group were reversed by medium-dose SFXF. Real-time PCR and western immunoblotting showed that the regulation of medium-dose SFXF in IL-4, IFN-γ, TNF-α, IL-1β, TLR7, MyD88, p38, and JNK was superior to Oseltamivir and high-dose SFXF group. Therefore, SFXF granules could reduce influenza infected cells and activation of T cells. |
url |
http://dx.doi.org/10.1155/2014/976364 |
work_keys_str_mv |
AT nanalu geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1 AT qiliu geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1 AT liganggu geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1 AT shijiege geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1 AT junwu geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1 AT qiuzeji geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1 AT zejiqiu geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1 AT hongchunzhang geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1 AT enxiangchao geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1 AT zhuonanyu geneexpressionprofilesunderlyingselectivetcellmediatedimmunityactivityofachinesemedicinegranuleonmiceinfectedwithinfluenzavirush1n1 |
_version_ |
1725775475067846656 |